Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N van Geel

Showing results (211-220 of 233) with videos related to

Pageof 24
Sort By:
European Journal of Cancer (Oxford, England : 1990)|November 11, 2006
The course of distress in women at increased risk of breast and ovarian cancer due to an (identified) genetic susceptibility who opt for prophylactic mastectomy and/or salpingo-oophorectomyP J C Bresser, C Seynaeve, A R Van Gool, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|October 3, 2002
Clinical experience of prophylactic mastectomy followed by immediate breast reconstruction in women at hereditary risk of breast cancer (HB(O)C) or a proven BRCA1 and BRCA2 germ-line mutationC M E Contant, M B E Menke-Pluijmers, C Seynaeve, et al.
Lancet (London, England)|July 8, 2000
Presymptomatic DNA testing and prophylactic surgery in families with a BRCA1 or BRCA2 mutationE J Meijers-Heijboer, L C Verhoog, C T Brekelmans, et al.
Urology|July 28, 2007
Prognosis of primary mucosal penile melanoma: a series of 19 Dutch patients and 47 patients from the literatureAlbertus N van Geel, Michael A den Bakker, Wim Kirkels, et al.
Annals of Surgical Oncology|May 26, 2011
Outcome after therapeutic lymph node dissection in patients with unknown primary melanoma siteSebastiaan P Prens, Augustinus P T van der Ploeg, Alexander C J van Akkooi, et al.
European Journal of Cancer (Oxford, England : 1990)|February 16, 2000
Histological determinants for different types of local recurrence after breast-conserving therapy of invasive breast cancer. Dutch Study Group on local Recurrence after Breast Conservation (BORST)A C Voogd, J L Peterse, M A Crommelin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 15, 2002
Determination of the molecular relationship between multiple tumors within one patient is of clinical importanceJoost R M van der Sijp, Jan P A M van Meerbeeck, Alex P W M Maat, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|April 10, 2022
Assessing the dynamic changes in vitiligo: reliability and validity of the Vitiligo Disease Activity Score (VDAS) and Vitiligo Disease Improvement Score (VDIS)N van Geel, L Depaepe, V Vandaele, et al.
Cancer|February 19, 1999
Local recurrence after breast conservation therapy for early stage breast carcinoma: detection, treatment, and outcome in 266 patients. Dutch Study Group on Local Recurrence after Breast Conservation (BORST)A C Voogd, G van Tienhoven, H L Peterse, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 11, 2003
Long-term psychological impact of carrying a BRCA1/2 mutation and prophylactic surgery: a 5-year follow-up studyIris van Oostrom, Hanne Meijers-Heijboer, Litanja N Lodder, et al.
Pageof 24

Showing results (211-220 of 233) with videos related to

Sort By:
Pageof 24
European Journal of Cancer (Oxford, England : 1990)|November 11, 2006
The course of distress in women at increased risk of breast and ovarian cancer due to an (identified) genetic susceptibility who opt for prophylactic mastectomy and/or salpingo-oophorectomyP J C Bresser, C Seynaeve, A R Van Gool, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|October 3, 2002
Clinical experience of prophylactic mastectomy followed by immediate breast reconstruction in women at hereditary risk of breast cancer (HB(O)C) or a proven BRCA1 and BRCA2 germ-line mutationC M E Contant, M B E Menke-Pluijmers, C Seynaeve, et al.
Lancet (London, England)|July 8, 2000
Presymptomatic DNA testing and prophylactic surgery in families with a BRCA1 or BRCA2 mutationE J Meijers-Heijboer, L C Verhoog, C T Brekelmans, et al.
Urology|July 28, 2007
Prognosis of primary mucosal penile melanoma: a series of 19 Dutch patients and 47 patients from the literatureAlbertus N van Geel, Michael A den Bakker, Wim Kirkels, et al.
Annals of Surgical Oncology|May 26, 2011
Outcome after therapeutic lymph node dissection in patients with unknown primary melanoma siteSebastiaan P Prens, Augustinus P T van der Ploeg, Alexander C J van Akkooi, et al.
European Journal of Cancer (Oxford, England : 1990)|February 16, 2000
Histological determinants for different types of local recurrence after breast-conserving therapy of invasive breast cancer. Dutch Study Group on local Recurrence after Breast Conservation (BORST)A C Voogd, J L Peterse, M A Crommelin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 15, 2002
Determination of the molecular relationship between multiple tumors within one patient is of clinical importanceJoost R M van der Sijp, Jan P A M van Meerbeeck, Alex P W M Maat, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|April 10, 2022
Assessing the dynamic changes in vitiligo: reliability and validity of the Vitiligo Disease Activity Score (VDAS) and Vitiligo Disease Improvement Score (VDIS)N van Geel, L Depaepe, V Vandaele, et al.
Cancer|February 19, 1999
Local recurrence after breast conservation therapy for early stage breast carcinoma: detection, treatment, and outcome in 266 patients. Dutch Study Group on Local Recurrence after Breast Conservation (BORST)A C Voogd, G van Tienhoven, H L Peterse, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 11, 2003
Long-term psychological impact of carrying a BRCA1/2 mutation and prophylactic surgery: a 5-year follow-up studyIris van Oostrom, Hanne Meijers-Heijboer, Litanja N Lodder, et al.
Pageof 24